Transactiva will participate in the 4th edition of the Healthtech Innovation days (HTID®) and run for the HealthTech For Care Innovation Award. The HTID® event, organized by the HealthTech For Care (HTFC) endowment fund, and taking place both online and at the Health Tech Space in Paris (France), on 13th and 14th October 2022,   combines one-on-one meetings between innovative European healthcare companies (Biotech, Medtech, Innovative Services & Digital Health), investors, industrial and pharmaceutical companies, as well as conferences and roundtables led by international KOLs. 

The HTID® event is launching for the first time a pitch competition for European healthcare companies committed to patients. The purpose is to offer these companies the opportunity to present their solutions to healthcare experts and investors. The selected companies from seven European countries are A4Cell, AbolerIS Pharma, Abscint, ANeuroTech, Aptus, Bloomlife, Clouds of Care, E-scopics, FluoSphera, Iomed, Lattice Medical, mimiX biotherapeutics, Neomatrix, Neuropath, Predilife, Pulsify Medical, Radiomics, Regen Lab, Smart immune, Transactiva, Vidac Pharma Ltd., Leucid Bio, miDiagnostics, MRM Health & Yoni Solutions.
The winner will receive the “HealthTech For Care innovation” award, which goes along with privileged connections with HTFC sponsors, visibility through dedicated communication and free access to the 5th edition of the HealthTech Innovation Days (HTID®) event.

For more information, please visit the HealthTech for Care website.

Transactiva@ Healthtech Innovation days (HTID®) and HealthTech For Care Innovation Award 2022
Tagged on: